ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal
◽
10.1111/j.1445-5994.2009.01987.x
◽
2010
◽
Vol 40
(3)
◽
pp. 201-208
◽
Cited By ~ 4
Author(s):
S. Sewak
◽
S. Kosmider
◽
V. Ganju
◽
A. Woollett
◽
E. G. Yeow
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
Hormone Refractory
Download Full-text
Related Documents
Cited By
References
Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer
Oncology Reports
◽
10.3892/or.10.4.885
◽
2003
◽
Author(s):
C. Robles
◽
A. Furst
◽
P. Sriratana
◽
S. Lai
◽
L. Chua
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Low Dose
◽
Phase Ii Study
◽
Hormone Refractory
◽
Dose Prednisone
Download Full-text
Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study
Annals of Oncology
◽
10.1093/annonc/mdi096
◽
2005
◽
Vol 16
(3)
◽
pp. 419-424
◽
Cited By ~ 12
Author(s):
A. Font
◽
A. Murias
◽
F.R. García Arroyo
◽
C. Martin
◽
J. Areal
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
Hormone Refractory
Download Full-text
5-Fluorouracil and high dose folinic acid in hormone-refractory metastatic prostate cancer: A phase II study
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a058938
◽
1994
◽
Vol 5
(7)
◽
pp. 644-645
◽
Cited By ~ 9
Author(s):
S.D. Huan
◽
S.E. Aitken
◽
D.J. Stewart
Keyword(s):
Prostate Cancer
◽
Folinic Acid
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
High Dose
◽
Hormone Refractory
Download Full-text
Addition of DMXAA (ASA404) to docetaxel in patients with hormone-refractory metastatic prostate cancer (HRMPC): update from a randomized, phase II study
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.5007
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 5007-5007
◽
Cited By ~ 6
Author(s):
R. Pili
◽
M. Rosenthal
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Hormone Refractory
Download Full-text
Phase II study combining gefitinib with etoposide in patients with hormone-refractory metastatic prostate cancer (mHRPC) after docetaxel-based therapy.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.e15071
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. e15071-e15071
Author(s):
R. J. Hauke
◽
F. R. Loberiza
◽
J. E. Elkahwaji
◽
P. M. Townley
◽
G. K. Bascom
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
Hormone Refractory
Download Full-text
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients
Annals of Oncology
◽
10.1093/annonc/mdg342
◽
2003
◽
Vol 14
(8)
◽
pp. 1291-1298
◽
Cited By ~ 24
Author(s):
J.P. Droz
◽
X. Muracciole
◽
N. Mottet
◽
M. Ould Kaci
◽
J.M. Vannetzel
◽
...
Keyword(s):
Prostate Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Study
◽
Hormone Refractory
Download Full-text
A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)
European Journal of Cancer
◽
10.1016/s0959-8049(99)81827-9
◽
1999
◽
Vol 35
◽
pp. S349
◽
Cited By ~ 1
Author(s):
A. Einstein
◽
R. Lush
◽
R. Rago
◽
G. Bubley
◽
W.D. Henner
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Hormone Refractory Prostate Cancer
◽
Hormone Refractory
Download Full-text
Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer
Urology
◽
10.1016/s0090-4295(94)80096-0
◽
1994
◽
Vol 44
(3)
◽
pp. 377-380
◽
Cited By ~ 4
Author(s):
Robert Dreicer
◽
Paula Kforest
◽
Richard D. Williams
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Metastatic Prostate Cancer
◽
Phase Ii Trial
◽
Hormone Refractory
Download Full-text
Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study
European Urology
◽
10.1016/j.eururo.2007.02.060
◽
2007
◽
Vol 52
(4)
◽
pp. 1020-1027
◽
Cited By ~ 13
Author(s):
Giuseppe Di Lorenzo
◽
Riccardo Autorino
◽
Sisto Perdonà
◽
Michele De Laurentiis
◽
Massimo D'Armiento
◽
...
Keyword(s):
Prostate Cancer
◽
Zoledronic Acid
◽
Phase Ii
◽
Phase Ii Study
◽
Hormone Refractory Prostate Cancer
◽
Line Treatment
◽
First Line
◽
Hormone Refractory
◽
First Line Treatment
Download Full-text
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study
Cancer
◽
10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x
◽
1993
◽
Vol 72
(6)
◽
pp. 1965-1968
◽
Cited By ~ 26
Author(s):
Timothy M. Kuzel
◽
Martin S. Tallman
◽
Daniel Shevrin
◽
Edward Braud
◽
Lary Kilton
◽
...
Keyword(s):
Prostate Cancer
◽
Continuous Infusion
◽
Phase Ii
◽
Phase Ii Study
◽
Cancer Center
◽
Hormone Refractory Prostate Cancer
◽
Hormone Refractory
◽
Center Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close